{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T04:43:08Z","timestamp":1791088988294,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["americanjournalofsurgery.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Surgery"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1016\/j.amjsurg.2006.08.075","type":"journal-article","created":{"date-parts":[[2007,3,21]],"date-time":"2007-03-21T06:52:47Z","timestamp":1174459967000},"page":"476-481","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Increase in substance P precursor mRNA in noninflamed small-bowel sections in patients with Crohn\u2019s disease"],"prefix":"10.1016","volume":"193","author":[{"given":"Christoph W.","family":"Michalski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Autschbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Selvaggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio Francesco","family":"Di Mola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Roggo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierluigi","family":"Di Sebastiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus W.","family":"B\u00fcchler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Giese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut","family":"Friess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjsurg.2006.08.075_bib1","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s11894-001-0031-6","article-title":"A perspective on inflammatory bowel disease in the child and adolescent at the turn of the millennium","volume":"3","author":"Haller","year":"2001","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.amjsurg.2006.08.075_bib2","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0140-6736(98)10463-4","article-title":"Neuroimmune appendicitis","volume":"354","author":"Di Sebastiano","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.amjsurg.2006.08.075_bib3","first-page":"G769","article-title":"Intestinal inflammation: a complex interplay of immune and nonimmune cell interactions","volume":"273","author":"Fiocchi","year":"1997","journal-title":"Am J Physiol"},{"key":"10.1016\/j.amjsurg.2006.08.075_bib4","first-page":"62","article-title":"Substance P and vasoactive intestinal polypeptide but not calcitonin gene-related peptide concentrations are decreased in patients with moderate and severe ulcerative colitis","volume":"30","author":"Renzi","year":"1998","journal-title":"Ital J Gastroenterol Hepatol"},{"key":"10.1016\/j.amjsurg.2006.08.075_bib5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s003840050136","article-title":"Substance P containing nerve fibers in ulcerative colitis","volume":"13","author":"Watanabe","year":"1998","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.amjsurg.2006.08.075_bib6","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/003655299750026236","article-title":"Effect of substance P on histamine secretion from gut mucosa in inflammatory bowel disease","volume":"34","author":"Raithel","year":"1999","journal-title":"Scand J Gastroenterol"},{"issue":"Pt 3","key":"10.1016\/j.amjsurg.2006.08.075_bib7","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1113\/jphysiol.1995.sp020852","article-title":"Involvement of neurokinin receptors in the induction but not the maintenance of mechanical allodynia in rat flexor motoneurones","volume":"486","author":"Ma","year":"1995","journal-title":"J Physiol"},{"key":"10.1016\/j.amjsurg.2006.08.075_bib8","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/32897","article-title":"Primary afferent tachykinins are required to experience moderate to intense pain","volume":"392","author":"Cao","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.amjsurg.2006.08.075_bib9","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0196-9781(98)00159-4","article-title":"Modulation of the hypothalamo-pituitary-gonadal axis and the pineal gland by neurokinin A, neuropeptide K and neuropeptide gamma","volume":"20","author":"Debeljuk","year":"1999","journal-title":"Peptides"},{"key":"10.1016\/j.amjsurg.2006.08.075_bib10","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/0016-5085(95)90394-1","article-title":"Differential expression of substance P receptors in patients with Crohn\u2019s disease and ulcerative colitis","volume":"109","author":"Mantyh","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1016\/j.amjsurg.2006.08.075_bib11","article-title":"The role of substance P in inflammatory disease","volume":"201","author":"O\u2019Connor","year":"2004","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.amjsurg.2006.08.075_bib12","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1136\/gut.47.3.387","article-title":"Neurokinin-1 receptor expression in inflammatory bowel disease: molecular quantitation and localisation","volume":"47","author":"Goode","year":"2000","journal-title":"Gut"},{"key":"10.1016\/j.amjsurg.2006.08.075_bib13","first-page":"908","article-title":"Rectal substance P concentrations are increased in ulcerative colitis but not in Crohn\u2019s disease","volume":"88","author":"Bernstein","year":"1993","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.amjsurg.2006.08.075_bib14","first-page":"176","article-title":"Immunocytochemical localization of vasoactive intestinal peptide and substance P in the colon from normal subjects and patients with inflammatory bowel disease","volume":"87","author":"Mazumdar","year":"1992","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.amjsurg.2006.08.075_bib15","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1007\/BF02209015","article-title":"Changes in substance P-immunoreactive innervation of human colon associated with ulcerative colitis","volume":"40","author":"Keranen","year":"1995","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.amjsurg.2006.08.075_bib16","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/j.1440-1827.1994.tb01723.x","article-title":"Changes in neuropeptide-containing nerves in human colonic mucosa with inflammatory bowel disease","volume":"44","author":"Kimura","year":"1994","journal-title":"Pathol Int"},{"key":"10.1016\/j.amjsurg.2006.08.075_bib17","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/BF01296290","article-title":"Distribution and quantitation of gut neuropeptides in normal intestine and inflammatory bowel diseases","volume":"32","author":"Koch","year":"1987","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.amjsurg.2006.08.075_bib18","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0304-3940(94)90772-2","article-title":"Substance P binding sites on intestinal lymphoid aggregates and blood vessels in inflammatory bowel disease correspond to authentic NK-1 receptors","volume":"178","author":"Mantyh","year":"1994","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.amjsurg.2006.08.075_bib19","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1159\/000097323","article-title":"Mucosal substance P receptor expression in HIV infection and inflammatory bowel disease","volume":"4","author":"McGowan","year":"1997","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.amjsurg.2006.08.075_bib20","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0002-9440(10)64789-X","article-title":"Substance P (neurokinin-1) and neurokinin A (neurokinin-2) receptor gene and protein expression in the healthy and inflamed human intestine","volume":"157","author":"Renzi","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.amjsurg.2006.08.075_bib21","first-page":"G735","article-title":"Downregulation of neutral endopeptidase (EC 3.4.24.11) in the inflamed rat intestine","volume":"264","author":"Hwang","year":"1993","journal-title":"Am J Physiol"},{"key":"10.1016\/j.amjsurg.2006.08.075_bib22","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s00428-002-0684-z","article-title":"Cytokine\/chemokine messenger-RNA expression profiles in ulcerative colitis and Crohn\u2019s disease","volume":"441","author":"Autschbach","year":"2002","journal-title":"Virchows Arch"},{"key":"10.1016\/j.amjsurg.2006.08.075_bib23","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/sj.cgt.7700457","article-title":"Suppression of metastatic hemangiosarcoma by a parvovirus MVMp vector transducing the IP-10 chemokine into immunocompetent mice","volume":"9","author":"Giese","year":"2002","journal-title":"Cancer Gene Ther"},{"key":"10.1016\/j.amjsurg.2006.08.075_bib24","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1038\/labinvest.3780131","article-title":"Galectin-1 and galectin-3 in chronic pancreatitis","volume":"80","author":"Wang","year":"2000","journal-title":"Lab Invest"},{"key":"10.1016\/j.amjsurg.2006.08.075_bib25","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1038\/sj.onc.1208642","article-title":"Loss of BNIP3 expression is a late event in pancreatic cancer contributing to chemoresistance and worsened prognosis","volume":"24","author":"Erkan","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.amjsurg.2006.08.075_bib26","first-page":"36","article-title":"Image processing with Image","volume":"11","author":"Abramoff","year":"2004","journal-title":"J Biophotonics International"},{"key":"10.1016\/j.amjsurg.2006.08.075_bib27","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0889-8553(21)00568-9","article-title":"Neuroimmunomodulation in the intestinal mucosa","volume":"20","author":"Ottaway","year":"1991","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.amjsurg.2006.08.075_bib28","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1146\/annurev.me.40.020189.002013","article-title":"Neuropeptides and inflammation: the role of substance P","volume":"40","author":"Payan","year":"1989","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.amjsurg.2006.08.075_bib29","first-page":"91","article-title":"Innervation of mucosal immune cells in the gastrointestinal tract","volume":"4","author":"Stead","year":"1992","journal-title":"Reg Immunol"},{"key":"10.1016\/j.amjsurg.2006.08.075_bib30","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/0016-5085(80)90441-2","article-title":"Abnormalities of vasoactive intestinal polypeptide-containing nerves in Crohn\u2019s disease","volume":"79","author":"Bishop","year":"1980","journal-title":"Gastroenterology"},{"key":"10.1016\/j.amjsurg.2006.08.075_bib31","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1136\/gut.25.6.636","article-title":"Gastrointestinal regulatory peptide storage granule abnormalities in jejunal mucosal diseases","volume":"25","author":"Dawson","year":"1984","journal-title":"Gut"},{"key":"10.1016\/j.amjsurg.2006.08.075_bib32","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0165-5728(94)90164-3","article-title":"Eosinophils within the healthy or inflamed human intestine produce substance P and vasoactive intestinal peptide","volume":"52","author":"Metwali","year":"1994","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.amjsurg.2006.08.075_bib33","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1136\/gut.24.8.724","article-title":"Peptide-containing nerve fibres in the gut wall in Crohn\u2019s disease","volume":"24","author":"Sjolund","year":"1983","journal-title":"Gut"},{"key":"10.1016\/j.amjsurg.2006.08.075_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/S0026-895X(25)08831-5","article-title":"Differential activation of intracellular effector by two isoforms of human neurokinin-1 receptor","volume":"41","author":"Fong","year":"1992","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.amjsurg.2006.08.075_bib35","doi-asserted-by":"crossref","first-page":"9475","DOI":"10.1073\/pnas.94.17.9475","article-title":"A substance P (neurokinin-1) receptor mutant carboxyl-terminally truncated to resemble a naturally occurring receptor isoform displays enhanced responsiveness and resistance to desensitization","volume":"94","author":"Li","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.amjsurg.2006.08.075_bib36","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1046\/j.1471-4159.2003.01577.x","article-title":"Human substance P receptor lacking the C-terminal domain remains competent to desensitize and internalize","volume":"84","author":"Richardson","year":"2003","journal-title":"J Neurochem"},{"key":"10.1016\/j.amjsurg.2006.08.075_bib37","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1046\/j.1460-9568.2003.02600.x","article-title":"Neurokinin 1 receptor and relative abundance of the short and long isoforms in the human brain","volume":"17","author":"Caberlotto","year":"2003","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.amjsurg.2006.08.075_bib38","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/0006-8993(96)00050-9","article-title":"Differential expression of two isoforms of the neurokinin-1 (substance P) receptor in vivo","volume":"719","author":"Mantyh","year":"1996","journal-title":"Brain Res"},{"key":"10.1016\/j.amjsurg.2006.08.075_bib39","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1073\/pnas.91.3.947","article-title":"CP-96,345, a substance P antagonist, inhibits rat intestinal responses to Clostridium difficile toxin A but not cholera toxin","volume":"91","author":"Pothoulakis","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.amjsurg.2006.08.075_bib40","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1172\/JCI2039","article-title":"Neurokinin-1 (NK-1) receptor is required in Clostridium difficile-induced enteritis","volume":"101","author":"Castagliuolo","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.amjsurg.2006.08.075_bib41","first-page":"G68","article-title":"Substance P receptor expression in intestinal epithelium in clostridium difficile toxin A enteritis in rats","volume":"275","author":"Pothoulakis","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1016\/j.amjsurg.2006.08.075_bib42","doi-asserted-by":"crossref","first-page":"G1298","DOI":"10.1152\/ajpgi.2000.279.6.G1298","article-title":"NK-1 antagonist decreases colonic inflammation and oxidative stress in dextran sulfate-induced colitis in rats","volume":"279","author":"Stucchi","year":"2000","journal-title":"Am J Physiol Gastrointest Liver Physiol"}],"container-title":["The American Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002961007000050?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002961007000050?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T17:48:47Z","timestamp":1757699327000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002961007000050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["S0002961007000050"],"URL":"https:\/\/doi.org\/10.1016\/j.amjsurg.2006.08.075","relation":{},"ISSN":["0002-9610"],"issn-type":[{"value":"0002-9610","type":"print"}],"subject":[],"published":{"date-parts":[[2007,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increase in substance P precursor mRNA in noninflamed small-bowel sections in patients with Crohn\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjsurg.2006.08.075","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Excerpta Medica Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}